Dallas, TX -- May 8, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today confirmed the company plans to continue publishing weekly Covid-19 updates. The company has now published six weeks of updates and on Monday, May 11, 2020, it plans to publish its 7th week of updates.
The update this week included details and new information on the company’s past spinoff of its cannabis cultivation operation to Nouveau (NOUV) and the planned dividend of NOUV stock to PURA shareholders. PURA management confirmed its commitment to the success of the spinoff and a dividend to PURA shareholders.
The update on Monday will include more information on plans for the spinoff to include discussions that have started involving PURA’s cannabis cultivation spinoff working with NCM Biotech, a subsidiary of Kali-Extracts (KALY), to develop a proprietary cultivar for NCM Biotech’s ongoing efforts to produce a COPD treatment from its patented cannabis extraction process.
For more information on Puration, visit http://www.purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.